1 day ago
1
Panama7
- Sanofi (NASDAQ:SNY) to acquire US-based Blueprint Medicines for ~$9.1B, or $129.00 per share in cash, with the deal expected to close in Q3.
- Blueprint shareholders also will receive one non-tradeable contingent value right (CVR) which will entitle the
English (US) ·